Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SAfiledCriticalSynthelabo SA
Priority to FR9404290ApriorityCriticalpatent/FR2718442B1/fr
Publication of FR2718442A1publicationCriticalpatent/FR2718442A1/fr
Application grantedgrantedCritical
Publication of FR2718442B1publicationCriticalpatent/FR2718442B1/fr
C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
FR9404290A1994-04-121994-04-12Dérivés de 5-(1H-imidazol-4-yl)-1-oxopentylpipéridine, leur préparation et leur application en thérapeutique.
Expired - Fee RelatedFR2718442B1
(fr)